GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals

Glycogen synthase kinase-3 (GSK-3) is a regulator of signaling pathways. KRas is frequently mutated in pancreatic cancers. The growth of certain pancreatic cancers is KRas-dependent and can be suppressed by GSK-3 inhibitors, documenting a link between KRas and GSK-3. To further elucidate the roles o...

Full description

Saved in:
Bibliographic Details
Published in:Cells
Main Authors: Abrams, Stephen L., Akula, Shaw M., Meher, Akshaya K., Steelman, Linda S., Gizak, Agnieszka, Duda, Przemysław, Rakus, Dariusz, Martelli, Alberto M., Ratti, Stefano, Cocco, Lucio, Montalto, Giuseppe, Cervello, Melchiorre, Ruvolo, Peter, Libra, Massimo, Falzone, Luca, Candido, Saverio, McCubrey, James A.
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8067414/
https://ncbi.nlm.nih.gov/pubmed/33917370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10040816
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items